FDA
-
-
-
-
-
-
-
Devonian Reports Its Annual 2024 Financial Results
-
-
-
-
-
-
-
Devonian Seeks Shareholders Approval for Share Consolidation
-
-
-
-
-
-
-
Devonian Health Group Announces Presentation of Thykamine™ Efficacy Results in Atopic Dermatitis at the World Congress of Dermatology and Provides Thykamine™ Clinical Development Program Update.
-
-
-
-
-
-
-
Devonian Health Group Announces Executive Change and Grant of Stock Options
-
-
-
-
-
-
-
Devonian Announces Adoption of Restricted Share Unit Plan
-
-
-
-
-
-
-
Devonian Health Group Announces Publication of Article on Potential Use of Thykamine™ in the Treatment of Covid-19 in the International Journal of Noncommunicable Diseases
-
-
-
-
-
-
-
Devonian Health Group Announces Exclusive Distribution, Sales and Marketing Agreement for Purgenesis™ Anti-aging Products in Middle East Countries
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

